SION earnings date and last-quarter result: next report 2026-08-10, last quarter beat, P/E -23.33. Updated 2026-07-23.
Sionna Therapeutics (SION) Research Hub
Sionna Therapeutics (SION) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.69 USD (+2.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -23.33, market cap 2.04B. This hub links to the full technical, earnings and options research available for SION.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.69 USD (+2.50%) |
| 52-week range | 3.55 USD – 54.97 USD |
| Trend regime | Range |
| 14-day RSI | 24.3 (Oversold) |
| Trailing P/E | -23.33 |
| Market cap | 2.04B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for SION
Covered Call on SION: how it works, illustrative setup around the real 3.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SION: how it works, illustrative setup around the real 3.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SION: how it works, illustrative setup around the real 3.69 USD price, max profit/loss, breakeven and when to use it. Educational.
SION technical analysis: range, last 3.69 USD, RSI 24.3, 52w range 3.55 USD–54.97 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SION in?
Sionna Therapeutics (SION) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SION in an uptrend or downtrend?
As of 2026-10-26, SION is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SION's trailing P/E ratio?
SION's trailing P/E is -23.33, with a market cap of 2.04B. See the earnings research page for full valuation detail.
When does SION next report earnings?
SION is next scheduled to report earnings on 2026-08-10.